Literature DB >> 6814795

Opiate mediation of amenorrhoea in hyperprolactinaemia and in weight-loss related amenorrhoea.

A Grossman, P J Moult, H McIntyre, J Evans, T Silverstone, L H Rees, G M Besser.   

Abstract

Endogenous opiates are involved in the control of pituitary gonadotrophin and PRL secretion, and possibly of food intake. Both hyperprolactinaemia and weight loss (especially in anorexia nervosa) are frequently associated with amenorrhoea and an absence of gonadotrophin pulsatility. Since it has been suggested that increased endogenous opiate tone may operate in both conditions, we infused high-doses of naloxone into twelve patients with amenorrhoea of whom five had hyperprolactinaemia and seven had weight-loss related amenorrhoea. Eleven of the twelve patients had low levels of oestradiol (less than 50 pmol/l). Naloxone induced a marked rise in both LH and FSH levels in all of the five hyperprolactinaemic patients. In contrast, the patients with weight-loss amenorrhoea responded to naloxone with only a small or no rise in gonadotrophins. There was no consistent change in PRL in either group of patients. It is concluded that in hyperprolactinaemia, but not weight-loss amenorrhoea, there is an important endogenous opiate-mediated tonic inhibition of secretion of hypothalamic gonadotrophin releasing hormone.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6814795     DOI: 10.1111/j.1365-2265.1982.tb01603.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  10 in total

Review 1.  Hyperprolactinemia: neuroendocrine and diagnostic aspects.

Authors:  F Camanni; E Ciccarelli; E Ghigo; E E Müller
Journal:  J Endocrinol Invest       Date:  1989-10       Impact factor: 4.256

2.  Nufenoxole, a new antidiarrhoeal agent, inhibits fluid secretion in the human jejunum.

Authors:  K J Moriarty; D D Rolston; M J Kelly; M Shield; M L Clark
Journal:  Gut       Date:  1985-01       Impact factor: 23.059

Review 3.  Prolactinomas.

Authors:  A Grossman; G M Besser
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-19

4.  Effect of the pretreatment with prolactin on the distribution of immunoreactive beta-endorphin through different ovarian compartments in immature, superovulated rats.

Authors:  Fernando M Reis; Fernanda Polisseni; Virginia M Pereira; Geovanni D Cassali; Adelina M Reis; Alicia G Faletti; Aroldo F Camargos
Journal:  J Mol Histol       Date:  2004-11       Impact factor: 2.611

Review 5.  Sex steroid metabolism and menstrual irregularities in the exercising female. A review.

Authors:  C De Crée
Journal:  Sports Med       Date:  1998-06       Impact factor: 11.136

6.  Endorphins and exercise.

Authors:  V J Harber; J R Sutton
Journal:  Sports Med       Date:  1984 Mar-Apr       Impact factor: 11.136

Review 7.  GnRH pulses--the regulators of human reproduction.

Authors:  J C Marshall; A C Dalkin; D J Haisenleder; M L Griffin; R P Kelch
Journal:  Trans Am Clin Climatol Assoc       Date:  1993

Review 8.  Reproductive hormones and menstrual changes with exercise in female athletes.

Authors:  B Arena; N Maffulli; F Maffulli; M A Morleo
Journal:  Sports Med       Date:  1995-04       Impact factor: 11.136

9.  Short-term effects of ovariectomy: the opioid control of LH secretion in fertile climacteric and postmenopausal women.

Authors:  F Petraglia; G Comitini; G D'Ambrogio; A Volpe; F Facchinetti; G Alessandrini; A R Genazzani
Journal:  J Endocrinol Invest       Date:  1985-08       Impact factor: 4.256

10.  Opioid induced hypogonadism.

Authors:  Raghava G Reddy; Theingi Aung; Niki Karavitaki; John A H Wass
Journal:  BMJ       Date:  2010-08-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.